Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.91 USD | +3.85% | -8.36% | -25.13% |
10/05 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
09/05 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.13% | 284.54Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.22TCr | |
-3.46% | 2.13TCr | |
-5.57% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.86% | 1.68TCr | |
+37.57% | 1.25TCr | |
-26.24% | 808.97Cr |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Chardan Adjusts Price Target on Arrowhead Pharmaceuticals to $60 From $82, Keeps Buy Rating